Method of treatment of cancers
US-12036259-B2 · Jul 16, 2024 · US
Metabolism accelerating composition comprising Astragali radix extract
US9839660B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9839660-B2 |
| Application number | US-201013512800-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 29, 2010 |
| Priority date | Nov 30, 2009 |
| Publication date | Dec 12, 2017 |
| Grant date | Dec 12, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a composition comprising Astragali Radix extract as an active ingredient. The composition can increase body energy consumption and muscle metabolism. The present invention also relates to pharmaceutical and food compositions which include a composition comprising the Astragali Radix extract. The pharmaceutical and food compositions also increase body energy consumption and muscle metabolism.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for activating peroxisome proliferator-activated receptor gamma coactivator 1-alpha(PGC1-α) promoter, comprising: parenterally administering to a subject in need of increasing basal metabolic rate a composition comprising an active component and a pharmaceutically acceptable carrier, wherein the active component consists of an astragali radix powdered freeze-dried extract, wherein the astragali radix powdered freeze-dried extract content is comprised in an amount of 10-60 wt % based on the total weight of the composition, and wherein the composition promotes production of mitochondria in the subject, wherein the astragali radix powdered freeze-dried extract is prepared by mixing astragali radix with triply distilled water as a ratio of 1:10, extracting the mixture for 3 hours in an extractor and repeating the mixing and extracting 2 times, filtering the resulting extract through a filter paper, concentrating the filtrate under reduced pressure, and freeze-drying the concentrate to obtain dry powder of astragali radix extract. 2. The method according to claim 1 , wherein parenteral administration comprises injection. 3. The method according to claim 1 , wherein the pharmaceutically acceptable carrier comprises a diluent. 4. The method according to claim 3 , wherein the diluent is lactose.
Assignees
Inventors
Classifications
Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Drugs for disorders of the nervous system · CPC title
Plant extracts, their artificial duplicates or their derivatives · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9839660B2 cover?
- The present invention provides a composition comprising Astragali Radix extract as an active ingredient. The composition can increase body energy consumption and muscle metabolism. The present invention also relates to pharmaceutical and food compositions which include a composition comprising the Astragali Radix extract. The pharmaceutical and food compositions also increase body energy co…
- Who is the assignee on this patent?
- Park Pil Joon, Cho Si Young, Seo Dae Bang, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K36/481. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).